2025年人工智慧（AI）賦能的臨床試驗場地可行性全球市場報告

近年來，人工智慧（AI）賦能的臨床試驗場地可行性市場規模呈指數級成長，從2024年的12.4億美元成長到2025年的15.3億美元，複合年成長率達23.8%。這段歷史性成長時期主要受以下因素驅動：人工智慧在臨床研究中的應用日益廣泛、對更快招募患者的需求不斷成長、分散式臨床試驗的擴展、電子數據採集系統的進步以及監管機構對創新試驗設計的支持。

預計未來幾年，人工智慧 (AI) 賦能的臨床試驗中心可行性評估市場將呈指數級成長，到 2029 年市場規模將達到 35.5 億美元，複合年成長率 (CAGR) 為 23.4%。預測期內的成長預計將受到以下因素的驅動：真實世界數據與 AI 分析的整合、虛擬臨床試驗平台的擴展、精準醫療投資的增加、預測模型在中心選擇中的應用，以及 AI 賦能的自適應試驗設計的開發。預測期內的關鍵趨勢包括：利用預測分析最佳化中心選擇、整合真實世界數據以增強可行性評估、部署機器學習演算法以預測患者招募、採用雲端基礎的AI 平台進行協作式試驗規劃，以及應用自然語言處理技術評估中心績效數據。

由於市場參與企業對改善臨床試驗地點選擇和招募的需求不斷成長，臨床試驗數量的增加正在推動市場擴張。預計臨床試驗數量的成長將推動人工智慧驅動的臨床試驗地點可行性評估市場的發展。臨床試驗是在全球範圍內進行的研究，旨在評估新療法、藥物和醫療器材的安全性和有效性。臨床試驗數量的成長主要歸功於生物醫學研發資金的增加，因為公共和私營部門都認知到迫切需要創新的醫療保健解決方案。臨床試驗的擴展正在推動對人工智慧驅動的可行性評估工具的需求。研究機構需要先進的系統來確定最佳地點、評估試驗地點的性能並預測招募成功率。例如，英國製藥工業協會在2023年11月報告稱，英國啟動的產業贊助臨床試驗數量增加了4.3%，從2021年的394項增加到2022年的411項。因此，臨床試驗數量的增加正在推動對人工智慧驅動的臨床試驗地點可行性評估解決方案的需求。

在人工智慧 (AI) 賦能的臨床試驗中心可行性評估市場中，主要公司正致力於開發先進工具，例如基於 AI 的可行性評估和招募平台，以最佳化臨床試驗中心的選擇並簡化臨床試驗流程。這些平台利用 AI 和機器學習技術評估臨床實驗和臨床實驗數據，透過臨床實驗的受試者匹配，實現更準確的中心識別和更有效的患者招募。這縮短了臨床試驗週期，並提高了試驗成功率。例如，總部位於美國的綜合性研究和技術服務公司 ObjectiveHealth 於 2023 年 6 月推出了 AI 平台 ObjectiveScreen。 ObjectiveScreen 透過增強病患辨識、預審和保留，改善臨床試驗結果。透過直接連接電子健康記錄並應用機器學習演算法，ObjectiveScreen 可以識別高風險患者，並將他們配對到合適的臨床試驗中。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球範圍內人工智慧（AI）賦能的臨床試驗中心的可行性：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 終端用戶產業分析
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：成長率分析
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場表現：規模與成長，2019-2024年
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場預測：規模與成長，2024-2029年，2034年
• 全球人工智慧（AI）驅動的臨床實驗中心可行性：潛在市場規模（TAM）

第6章 市場細分

• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場（按組成部分分類）、實際結果和預測（2019-2024年、2024-2029年、2034年）
• 軟體
• 服務
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：按部署模式、性能和預測分類，2019-2024年、2024-2029年、2034年
• 雲端基礎的
• 本地部署
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：按應用、性能和預測分類，2019-2024年、2024-2029年、2034年
• 位置選擇
• 病患招募
• 通訊協定設計
• 績效分析
• 其他用途
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場（按最終用戶分類）：實際結果和預測（2019-2024年、2024-2029年、2034年）
• 製藥公司
• 受託研究機構
• 學術研究機構
• 醫院
• 其他最終用戶
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：細分軟體、按類型分類、實際結果和預測（2019-2024年、2024-2029年、2034年）
• 預測分析軟體
• 機器學習（ML）平台
• 自然語言處理（NLP）工具
• 數據視覺化軟體
• 臨床試驗管理系統 (CTMS) 整合軟體
• 真實世界數據（RWD）分析軟體
• 基於風險的監控（RBM）軟體
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：按服務、類型、實際結果和預測進行細分，2019-2024年、2024-2029年、2034年
• 可行性評估服務
• 選址服務
• 病患招募支援服務
• 資料管理和分析服務
• 通訊協定最佳化服務
• 監理合規支援服務
• 諮詢和顧問服務

第7章 區域和國家分析

• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場：按地區分類，實際結果和預測，2019-2024年、2024-2029年、2034年
• 全球人工智慧（AI）賦能的臨床試驗場地可行性市場（按國家/地區分類）：實際結果和預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 人工智慧（AI）賦能的臨床試驗場地可行性市場：競爭格局
• 人工智慧（AI）賦能的臨床試驗場地可行性市場：公司概況
  • Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Dassault Systemes SE
• Parexel International Corporation
• ZS Associates Inc.
• Veeva Systems Inc.
• Verily Life Sciences LLC
• Signant Health Holding Corp.
• Saama Technologies LLC
• Elligo Health Research Inc.
• ConcertAI Inc.
• Medable Inc.
• Science 37 Inc.
• Castor EDC Inc.
• Unlearn.AI Inc.
• Antidote Technologies Inc.
• Deep 6 AI

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年人工智慧（AI）賦能的臨床試驗場地可行性市場：提供新機會的國家
• 2029年人工智慧（AI）賦能的臨床試驗場地可行性市場：提供新機會的細分領域
• 2029年人工智慧（AI）賦能的臨床試驗場地可行性市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Artificial intelligence (AI)-powered clinical trial site feasibility refers to platforms and services that use advanced algorithms to assess and identify the most suitable clinical trial sites. These solutions process large datasets to forecast site performance and patient recruitment potential. They improve the speed and accuracy of decision-making, reduce the likelihood of trial delays, and streamline feasibility assessments while enhancing overall operational efficiency.

The primary component types of AI-powered clinical trial site feasibility are software and services. Software consists of AI-driven platforms and tools that evaluate trial data, site performance, and patient demographics to optimize site selection and feasibility. Deployment options include cloud-based and on-premises models, supporting applications such as site selection, patient recruitment, protocol design, performance analytics, and more. Key end-users include pharmaceutical companies, contract research organizations, academic research institutes, hospitals, and other healthcare entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-powered clinical trial site feasibility market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered clinical trial site feasibility market statistics, including artificial intelligence (AI)-powered clinical trial site feasibility industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered clinical trial site feasibility market share, detailed artificial intelligence (AI)-powered clinical trial site feasibility market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered clinical trial site feasibility industry. The artificial intelligence (AI)-powered clinical trial site feasibility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered clinical trial site feasibility market size has grown exponentially in recent years. It will grow from $1.24 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 23.8%. Growth during the historic period was driven by the rising adoption of AI in clinical research, increasing demand for faster patient recruitment, expansion of decentralized clinical trials, advancements in electronic data capture systems, and regulatory support for innovative trial designs.

The artificial intelligence (AI)-powered clinical trial site feasibility market size is expected to see exponential growth in the next few years. It will grow to $3.55 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. Growth in the forecast period is expected to be fueled by the integration of real-world data with AI analytics, expansion of virtual clinical trial platforms, rising investment in precision medicine, adoption of predictive modeling for site selection, and development of adaptive trial designs powered by AI. Key trends anticipated for the forecast period include the use of predictive analytics to optimize site selection, integration of real-world data to strengthen feasibility assessments, deployment of machine learning algorithms to forecast patient recruitment, adoption of cloud-based AI platforms for collaborative trial planning, and application of natural language processing to evaluate site performance data.

The increase in clinical trials is contributing to the expansion of the market due to rising demand for improved trial site selection and participant enrollment. The anticipated growth in clinical trials is expected to drive the artificial intelligence powered clinical trial site feasibility market in the future. Clinical trials are research studies conducted worldwide to evaluate the safety and effectiveness of new medical treatments, drugs, and devices. This rise in clinical trials is largely the result of increased funding in biomedical research and development, as both public and private sectors acknowledge the urgent need for innovative healthcare solutions. The expansion of clinical trials fuels the need for artificial intelligence powered feasibility tools, as research organizations require advanced systems to identify the most suitable locations, evaluate site performance, and estimate enrollment success. For example, in November 2023, the Association of the British Pharmaceutical Industry reported that the number of industry-sponsored clinical trials initiated in the United Kingdom grew by 4.3 percent, increasing from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is driving the demand for artificial intelligence powered clinical trial site feasibility solutions.

Key companies operating in the artificial intelligence powered clinical trial site feasibility market are concentrating on the development of advanced tools such as artificial intelligence based feasibility and recruitment platforms to enhance site selection and streamline operations within clinical trials. These platforms use artificial intelligence and machine learning technologies to evaluate trial protocols and site data, allowing for better identification of clinical sites and more effective patient recruitment through accurate participant matching. This accelerates trial timelines and increases the chances of success. For example, in June 2023, ObjectiveHealth, a company based in the United States that offers integrated research and technology services, introduced ObjectiveScreen, a platform powered by artificial intelligence that improves clinical trial outcomes by enhancing patient identification, prequalification, and retention. It connects directly with electronic health records and applies machine learning algorithms to identify high-risk individuals and match them with appropriate trials, thereby speeding up recruitment and improving overall trial performance.

In February 2023, ZS Associates, a United States based technology and consulting firm, acquired Trials.ai for an undisclosed amount. This acquisition aims to strengthen ZS Associates' role in the healthcare industry by enhancing the efficiency of clinical trials, shortening the time required to bring therapies to market, and improving the experience of trial participants. Trials.ai is a United States based company focused on healthcare that provides artificial intelligence and analytics solutions to support and improve clinical trial site feasibility.

Major players in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systemes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI.

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered clinical trial site feasibility report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered clinical trial site feasibility market includes revenues earned by providing services such as site identification and selection, predictive enrollment modeling, investigator performance analysis, risk assessment and mitigation, and patient population analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-powered clinical trial site feasibility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered clinical trial site feasibility ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered clinical trial site feasibility market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Deployment Mode: Cloud-Based; On-Premises
• 3) By Application: Site Selection; Patient Recruitment; Protocol Design; Performance Analytics; Other Applications
• 4) By End-User: Pharmaceutical Companies; Contract Research Organizations; Academic Research Institutes; Hospitals; Other End-Users
• Subsegments:
• 1) By Software: Predictive Analytics Software; Machine Learning (ML) Platforms; Natural Language Processing (NLP) Tools; Data Visualization Software; Clinical Trial Management System (CTMS) Integration Software; Real-World Data (RWD) Analytics Software; Risk-Based Monitoring (RBM) Software
• 2) By Services: Feasibility Assessment Services; Site Selection Services; Patient Recruitment Support Services; Data Management And Analytics Services; Protocol Optimization Services; Regulatory Compliance Support Services; Consulting And Advisory Services
• Companies Mentioned: Oracle Corporation; Thermo Fisher Scientific Inc.; NVIDIA Corporation; IQVIA Holdings Inc.; Labcorp Holdings Inc.; Dassault Systemes SE; Parexel International Corporation; ZS Associates Inc.; Veeva Systems Inc.; Verily Life Sciences LLC; Signant Health Holding Corp.; Saama Technologies LLC; Elligo Health Research Inc.; ConcertAI Inc.; Medable Inc.; Science 37 Inc.; Castor EDC Inc.; Unlearn.AI Inc.; Antidote Technologies Inc.; Deep 6 AI
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Characteristics

3. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmentation

• 6.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• 6.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site Selection
• Patient Recruitment
• Protocol Design
• Performance Analytics
• Other Applications
• 6.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes
• Hospitals
• Other End-Users
• 6.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics Software
• Machine Learning (ML) Platforms
• Natural Language Processing (NLP) Tools
• Data Visualization Software
• Clinical Trial Management System (CTMS) Integration Software
• Real-World Data (RWD) Analytics Software
• Risk-Based Monitoring (RBM) Software
• 6.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Feasibility Assessment Services
• Site Selection Services
• Patient Recruitment Support Services
• Data Management And Analytics Services
• Protocol Optimization Services
• Regulatory Compliance Support Services
• Consulting And Advisory Services

7. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 9.1. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 9.2. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 10.1. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 11.1. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 11.2. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 12.1. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 13.1. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 14.1. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 14.2. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 15.1. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 15.2. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 16.1. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 17.1. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 18.1. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 19.1. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 20.1. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 21.1. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 22.1. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 23.1. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 23.2. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 24.1. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 24.2. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 25.1. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 25.2. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 26.1. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 26.2. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 27.1. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 28.1. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 28.2. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 29.1. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 29.2. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape
• 30.2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Company Profiles
  • 30.2.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Other Major And Innovative Companies

• 31.1. Dassault Systemes SE
• 31.2. Parexel International Corporation
• 31.3. ZS Associates Inc.
• 31.4. Veeva Systems Inc.
• 31.5. Verily Life Sciences LLC
• 31.6. Signant Health Holding Corp.
• 31.7. Saama Technologies LLC
• 31.8. Elligo Health Research Inc.
• 31.9. ConcertAI Inc.
• 31.10. Medable Inc.
• 31.11. Science 37 Inc.
• 31.12. Castor EDC Inc.
• 31.13. Unlearn.AI Inc.
• 31.14. Antidote Technologies Inc.
• 31.15. Deep 6 AI

32. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

35. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer